Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dengvaxia
Pharma
Takeda's dengue vaccine gets moved up in the FDA review queue
Takeda's dengue fever vaccine, Qdenga, has received priority review from the FDA for its biologics license application.
Kevin Dunleavy
Nov 23, 2022 10:30am
Takeda's dengue vaccine nod in Indonesia is the first of many
Sep 9, 2022 7:03am
Takeda opens €130M plant to produce dengue vaccine
Nov 6, 2019 10:34am
Pfizer, anemia drugs, Chinese scientists and more—FiercePharmaAsia
Aug 23, 2019 10:16am
Philippines officials nix Sanofi's appeal on Dengvaxia ban
Aug 22, 2019 10:53am
Botox rival, FDA inspections, Daiichi and more—FiercePharmaAsia
Aug 9, 2019 10:50am
